United-Guardian Reports Q2 2026 Results

United-Guardian, a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients, announced its financial results for the second quarter and first half of 2026. For Q2 2026, net sales increased 10% to $3.11 million from $2.84 million in Q2 2025, and net income rose 16% to $728,579 ($0.16 per share) from $626,826 ($0.14 per share). For the six months ended June 30, 2026, net sales grew 12% to $5.98 million from $5.32 million, and net income increased 30% to $1.55 million ($0.34 per share) from $1.19 million ($0.26 per share). The growth was driven by a 44% increase in cosmetic ingredient sales in Q2 and a 34% increase in the first half, largely due to increased purchases by Ashland Specialty Ingredients (ASI), the company's largest cosmetic distributor, which had reduced its inventory levels. Pharmaceutical sales rose 1% in Q2 and 11% in the first half, led by Renacidin, the company's most important pharmaceutical product. President Donna Vigilante expressed satisfaction with the results and outlined growth plans including expanding promotional efforts for Renacidin and increasing awareness of natural products.